ATI RN
ATI RN Custom Exams Set 5
1. Are M6 practical nurses utilized in field units with patient holding capabilities?
- A. Yes
- B. No
- C. -
- D. -
Correct answer: A
Rationale: Yes, M6 practical nurses are utilized in field units with patient holding capabilities. These nurses play a crucial role in providing care and support in various healthcare settings. Given this context, the correct answer is 'Yes.' Choice B, 'No,' is incorrect because M6 practical nurses can indeed work in field units with patient holding capabilities, as stated in the extract. Choices C and D are not applicable in this question.
2. What is the primary goal of care for a client diagnosed with sickle cell anemia?
- A. The client will call the healthcare provider if feeling ill.
- B. The client will be compliant with the medical regimen.
- C. The client will live as normal a life as possible.
- D. The client will verbalize understanding of treatments.
Correct answer: C
Rationale: The correct answer is C: 'The client will live as normal a life as possible.' For a client with sickle cell anemia, the primary goal of care is to promote a good quality of life by managing symptoms, preventing crises, and enhancing overall well-being. Option A is incorrect as it focuses on a specific action rather than the overall goal of care. Option B is important but not the primary goal; compliance is a means to achieve better health outcomes. Option D is also important but does not address the holistic approach of helping the client maintain a normal lifestyle despite their condition.
3. The nurse is analyzing laboratory values for the assigned clients. Which finding, based on the client's medical history, indicates the need for immediate follow-up?
- A. Client with chronic kidney disease and serum creatinine of 1.6 mg/dL
- B. Client with diabetes mellitus and a glycosylated hemoglobin A1c (HbA1c) of 7.0%
- C. Client with heart failure and a B-type natriuretic peptide (BNP) of 140 pg/mL
- D. Client who is male and has anemia with hemoglobin of 16.5 g/dL and hematocrit of 45%
Correct answer: B
Rationale: An HbA1c of 7.0% in a client with diabetes mellitus indicates poor long-term glucose control, necessitating immediate follow-up. Choice A, chronic kidney disease with a serum creatinine of 1.6 mg/dL, though concerning, does not indicate an immediate need for follow-up. Choice C, heart failure with a BNP of 140 pg/mL, may require monitoring but not immediate follow-up. Choice D, a male client with anemia and normal hemoglobin and hematocrit levels, does not warrant immediate attention based on the provided information.
4. A client with type 1 diabetes is diagnosed with diabetic ketoacidosis and initially treated with intravenous fluids followed by an IV bolus of regular insulin. The nurse anticipates that the practitioner will prescribe a continuous infusion of insulin of:
- A. Novolin L insulin
- B. Novolin R insulin
- C. Novolin N insulin
- D. Novolin U insulin
Correct answer: B
Rationale: The correct answer is Novolin R (Regular insulin) because it is used for continuous infusion to treat diabetic ketoacidosis. Novolin R has a rapid onset of action, making it suitable for this acute situation. Novolin L insulin (Choice A) is not typically used for continuous infusion in diabetic ketoacidosis. Novolin N insulin (Choice C) is an intermediate-acting insulin and is not ideal for rapid correction needed in diabetic ketoacidosis. Novolin U insulin (Choice D) is an ultra-long-acting insulin and is not appropriate for the immediate correction required in this scenario.
5. The client is diagnosed with hereditary spherocytosis. Which treatment/procedure would the nurse prepare the client to receive?
- A. Bone marrow transplant
- B. Splenectomy
- C. Frequent blood transfusions
- D. Liver biopsy
Correct answer: B
Rationale: The correct answer is B: Splenectomy. Splenectomy is the treatment of choice for hereditary spherocytosis. By removing the spleen, the excessive destruction of red blood cells is reduced, preventing hemolysis and improving anemia. Bone marrow transplant (A) is not a standard treatment for hereditary spherocytosis. Frequent blood transfusions (C) may temporarily address anemia but do not treat the underlying cause. Liver biopsy (D) is not indicated as a primary treatment for hereditary spherocytosis.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access